Articles with public access mandates - Moshe OrenLearn more
Not available anywhere: 4
Writing and reading H2B monoubiquitylation
G Fuchs, M Oren
Biochimica Et Biophysica Acta (BBA)-Gene Regulatory Mechanisms 1839 (8), 694-701, 2014
Mandates: European Commission
The translation initiation factor DAP5 promotes IRES-driven translation of p53 mRNA
S Weingarten-Gabbay, D Khan, N Liberman, Y Yoffe, S Bialik, S Das, ...
Oncogene 33 (5), 611-618, 2014
Mandates: Council of Scientific and Industrial Research, India, Department of …
Interference with the p53 family network contributes to the gain of oncogenic function of mutant p53 in hepatocellular carcinoma
T Schilling, A Kairat, G Melino, PH Krammer, W Stremmel, M Oren, ...
Biochemical and biophysical research communications 394 (3), 817-823, 2010
Mandates: German Research Foundation
Simultaneous measurement of genome-wide transcription elongation speeds and rates of RNA polymerase II transition into active elongation with 4sUDRB-seq
G Fuchs, Y Voichek, M Rabani, S Benjamin, S Gilad, I Amit, M Oren
Nature protocols 10 (4), 605-618, 2015
Mandates: European Commission
Available somewhere: 81
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
L Galluzzi, I Vitale, SA Aaronson, JM Abrams, D Adam, P Agostinis, ...
Cell Death & Differentiation 25 (3), 486-541, 2018
Mandates: US National Institutes of Health, Cancer Research UK, UK Medical Research …
The first 30 years of p53: growing ever more complex
AJ Levine, M Oren
Nature reviews cancer 9 (10), 749-758, 2009
Mandates: US National Institutes of Health
Mutant p53 gain-of-function in cancer
M Oren, V Rotter
Cold Spring Harbor perspectives in biology 2 (2), a001107, 2010
Mandates: US National Institutes of Health
Extracellular vesicle and particle biomarkers define multiple human cancers
A Hoshino, HS Kim, L Bojmar, KE Gyan, M Cioffi, J Hernandez, ...
Cell 182 (4), 1044-1061. e18, 2020
Mandates: US Department of Defense, US National Institutes of Health, Alex's Lemonade …
Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes
L Galluzzi, SA Aaronson, J Abrams, ES Alnemri, DW Andrews, ...
Cell Death & Differentiation 16 (8), 1093-1107, 2009
Mandates: US National Institutes of Health
Mutant p53 prolongs NF-κB activation and promotes chronic inflammation and inflammation-associated colorectal cancer
T Cooks, IS Pateras, O Tarcic, H Solomon, AJ Schetter, S Wilder, ...
Cancer cell 23 (5), 634-646, 2013
Mandates: US National Institutes of Health, Cancer Research UK
Requirement of ATM-dependent monoubiquitylation of histone H2B for timely repair of DNA double-strand breaks
L Moyal, Y Lerenthal, M Gana-Weisz, G Mass, S So, SY Wang, B Eppink, ...
Molecular cell 41 (5), 529-542, 2011
Mandates: US National Institutes of Health
Monoubiquitinated H2B is associated with the transcribed region of highly expressed genes in human cells
N Minsky, E Shema, Y Field, M Schuster, E Segal, M Oren
Nature cell biology 10 (4), 483-488, 2008
Mandates: US National Institutes of Health
Drugging p53 in cancer: one protein, many targets
O Hassin, M Oren
Nature Reviews Drug Discovery 22 (2), 127-144, 2023
Mandates: US National Science Foundation
The histone H2B-specific ubiquitin ligase RNF20/hBRE1 acts as a putative tumor suppressor through selective regulation of gene expression
E Shema, I Tirosh, Y Aylon, J Huang, C Ye, N Moskovits, N Raver-Shapira, ...
Genes & development 22 (19), 2664-2676, 2008
Mandates: US National Institutes of Health
Modulation of the vitamin D3 response by cancer-associated mutant p53
P Stambolsky, Y Tabach, G Fontemaggi, L Weisz, R Maor-Aloni, Z Sigfried, ...
Cancer cell 17 (3), 273-285, 2010
Mandates: US National Institutes of Health
Mdm2 regulates p53 mRNA translation through inhibitory interactions with ribosomal protein L26
Y Ofir-Rosenfeld, K Boggs, D Michael, MB Kastan, M Oren
Molecular cell 32 (2), 180-189, 2008
Mandates: US National Institutes of Health
A systematic p53 mutation library links differential functional impact to cancer mutation pattern and evolutionary conservation
E Kotler, O Shani, G Goldfeld, M Lotan-Pompan, O Tarcic, A Gershoni, ...
Molecular cell 71 (1), 178-190. e8, 2018
Mandates: European Commission
The gut microbiome switches mutant p53 from tumour-suppressive to oncogenic
E Kadosh, I Snir-Alkalay, A Venkatachalam, S May, A Lasry, E Elyada, ...
Nature 586 (7827), 133-138, 2020
Mandates: Worldwide Cancer Research, UK, European Commission
p53: guardian of ploidy
Y Aylon, M Oren
Molecular oncology 5 (4), 315-323, 2011
Mandates: US National Institutes of Health
Pathways and therapeutic targets in melanoma
E Shtivelman, MA Davies, P Hwu, J Yang, M Lotem, M Oren, KT Flaherty, ...
Oncotarget 5 (7), 1701, 2014
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program